IMPNF yields 4000.00% · PFE yields 6.13%● Live data
📍 IMPNF pulled ahead of the other in Year 1
Combined, IMPNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IMPNF + PFE for your $10,000?
Imperial Mining Group Ltd. operates as a mineral exploration company in Canada. The company primarily explores for copper-zinc, gold, scandium-niobium-tantalum, and silver deposits. The company holds interests in the Crater Lake project comprising 96 contiguous claims covering an area of 47 square kilometers located to the northeast of Schefferville, Quebec; and the Opawica project, which includes 42 contiguous mining titles in Gand and Lespérance townships covering an area of 23.45 square kilometers situated to the east of Desmaraisville in the Chibougamau mining camp. It also holds interests in the Carheil property comprising 100 contiguous claims covering an area of approximately 46.47 square kilometers; and the Brouillan property, which includes 13 claims covering a surface area of approximately 7.22 square kilometers located in the north of the town of La Sarre. In addition, the company holds an interest in the La Ronciere project, which consists of 45 mining claims covering an area of 25.1 square kilometers in Gand and La Roncière townships. Imperial Mining Group Ltd. is based in Montreal, Canada.
Full IMPNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.